Cargando…
New quinoxaline compounds as DPP-4 inhibitors and hypoglycemics: design, synthesis, computational and bio-distribution studies
The current work represents the design and synthetic approaches of a new set of compounds 6–10 bearing the 1,4-dimethyl-2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-sulfonamide scaffold. The biological evaluation revealed that most of the new compounds were promising selective dipeptidyl peptidase-IV (...
Autores principales: | Syam, Yasmin M., Anwar, Manal M., Abd El-Karim, Somaia S., Elseginy, Samia A., Essa, Basma M., Sakr, Tamer M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043576/ https://www.ncbi.nlm.nih.gov/pubmed/35494381 http://dx.doi.org/10.1039/d1ra06799k |
Ejemplares similares
-
New Quinoxaline-Based Derivatives as PARP-1 Inhibitors: Design, Synthesis, Antiproliferative, and Computational Studies
por: Syam, Yasmin M., et al.
Publicado: (2022) -
Synthesis and hypoglycemic activity of quinoxaline derivatives
por: Jia, Weidong, et al.
Publicado: (2023) -
In silico analysis of SARS-CoV-2 papain-like protease potential inhibitors
por: Elseginy, Samia A., et al.
Publicado: (2021) -
Pharmacophore-Based Virtual Screening and Molecular
Dynamics Simulation for Identification of a Novel DNA Gyrase B Inhibitor
with Benzoxazine Acetamide Scaffold
por: Elseginy, Samia A., et al.
Publicado: (2021) -
Anti-Alzheimer activity of new coumarin-based derivatives targeting acetylcholinesterase inhibition
por: Kamel, Nahla N., et al.
Publicado: (2023)